Nature Communications soon to be fully open access From 20th October Nature Communications, will become fully open access for all new submissions. If an author has a manuscript they wish to submit to the journal via the subscription route, they must submit before 20th October. After this date all new submissions, if accepted, will be published open access and an article processing charge (APC) will apply. For any questions on the switch, open access or advice on policies and funding, visit our website, read the press release or contact our dedicated support team at openaccess@nature.com. | | | | | | Editorial | Top | | Leap of FaithRick Morgan Mol Ther 2014 22: 1717-1718; 10.1038/mt.2014.165 Full Text | | In This Issue | Top | | In This IssueMol Ther 2014 22: 1720; 10.1038/mt.2014.166 Full Text | | Research Highlights | Top | | Research HighlightsMol Ther 2014 22: 1721; 10.1038/mt.2014.167 Full Text | | Commentaries | Top | | Parasites, Probiotics, and Piglets: A Novel Approach to IBDEileen Devaney Mol Ther 2014 22: 1722-1723; 10.1038/mt.2014.168 Full Text | | | | Small-Molecule Therapies for Genetic Skin FragilityLeena Bruckner-Tuderman Mol Ther 2014 22: 1724-1725; 10.1038/mt.2014.169 Full Text | | | | Engineered Antibody Therapies Coming of Age for Aging BrainsAnne Messer Mol Ther 2014 22: 1725-1727; 10.1038/mt.2014.170 Full Text | | | | Peptide Targeting of Mitochondria Elicits Testosterone FormationMichelangelo Campanella Mol Ther 2014 22: 1727-1729; 10.1038/mt.2014.171 Full Text | | Original Articles | Top | | A Transgenic Probiotic Secreting a Parasite Immunomodulator for Site-Directed Treatment of Gut InflammationRose A Whelan, Sebastian Rausch, Friederike Ebner, Dorothee Günzel, Jan F Richter, Nina A Hering, Jörg-Dieter Schulzke, Anja A Kühl, Ahmed Keles, Pawel Janczyk, Karsten Nöckler, Lothar H Wieler and Susanne Hartmann Mol Ther 2014 22: 1730-1740; advance online publication, July 2, 2014; 10.1038/mt.2014.125 Abstract | Full Text | | | | Aminoglycosides Restore Full-length Type VII Collagen by Overcoming Premature Termination Codons: Therapeutic Implications for Dystrophic Epidermolysis BullosaJon Cogan, Jacqueline Weinstein, Xinyi Wang, Yingping Hou, Sabrina Martin, Andrew P South, David T Woodley and Mei Chen Mol Ther 2014 22: 1741-1752; advance online publication, July 23, 2014; 10.1038/mt.2014.140 Abstract | Full Text | | | | ESCRT-mediated Uptake and Degradation of Brain-targeted α-synuclein Single Chain Antibody Attenuates Neuronal Degeneration In VivoMTOPENBrian Spencer, Sharareh Emadi, Paula Desplats, Simona Eleuteri, Sarah Michael, Kori Kosberg, Jay Shen, Edward Rockenstein, Christina Patrick, Anthony Adame, Tania Gonzalez, Michael Sierks and Eliezer Masliah Mol Ther 2014 22: 1753-1767; advance online publication, July 10, 2014; 10.1038/mt.2014.129 Abstract | Full Text | | | | Chaperone Nanobodies Protect Gelsolin Against MT1-MMP Degradation and Alleviate Amyloid Burden in the Gelsolin Amyloidosis Mouse ModelWouter Van Overbeke, Adriaan Verhelle, Inge Everaert, Olivier Zwaenepoel, Joël Vandekerckhove, Claude Cuvelier, Wim Derave and Jan Gettemans Mol Ther 2014 22: 1768-1778; advance online publication, July 15, 2014; 10.1038/mt.2014.132 Abstract | Full Text | | | | Induction of Androgen Formation in the Male by a TAT-VDAC1 Fusion Peptide Blocking 14-3-3ε Protein Adaptor and Mitochondrial VDAC1 InteractionsYasaman Aghazadeh, Daniel B Martinez-Arguelles, Jinjiang Fan, Martine Culty and Vassilios Papadopoulos Mol Ther 2014 22: 1779-1791; advance online publication, June 20, 2014; 10.1038/mt.2014.116 Abstract | Full Text | | | | Myocyte-mediated Arginase Expression Controls Hyperargininemia but not Hyperammonemia in Arginase-deficient MiceChuhong Hu, Jennifer Kasten, Hana Park, Ragini Bhargava, Denise S Tai, Wayne W Grody, Quynh G Nguyen, Stephen D Hauschka, Stephen D Cederbaum and Gerald S Lipshutz Mol Ther 2014 22: 1792-1802; advance online publication, June 3, 2014; 10.1038/mt.2014.99 Abstract | Full Text | | | | Effects of Vector Backbone and Pseudotype on Lentiviral Vector-mediated Gene Transfer: Studies in Infant ADA-Deficient Mice and Rhesus MonkeysDenise Carbonaro Sarracino, Alice F Tarantal, C Chang I. Lee, Michele Martinez, Xiangyang Jin, Xiaoyan Wang, Cinnamon L Hardee, Sabine Geiger, Christoph A Kahl and Donald B Kohn Mol Ther 2014 22: 1803-1816; advance online publication, June 13, 2014; 10.1038/mt.2014.88 Abstract | Full Text | | | | Serum-stabilized Naked Caspase-3 siRNA Protects Autotransplant Kidneys in a Porcine ModelCheng Yang, Tian Zhao, Zitong Zhao, Yichen Jia, Long Li, Yufang Zhang, Mangen Song, Ruiming Rong, Ming Xu, Michael L Nicholson, Tongyu Zhu and Bin Yang Mol Ther 2014 22: 1817-1828; advance online publication, June 16, 2014; 10.1038/mt.2014.111 Abstract | Full Text | | | | MicroRNA-103-1 Selectively Downregulates Brain NCX1 and Its Inhibition by Anti-miRNA Ameliorates Stroke Damage and Neurological DeficitsAntonio Vinciguerra, Luigi Formisano, Pierpaolo Cerullo, Natascia Guida, Ornella Cuomo, Alba Esposito, Gianfranco Di Renzo, Lucio Annunziato and Giuseppe Pignataro Mol Ther 2014 22: 1829-1838; advance online publication, June 23, 2014; 10.1038/mt.2014.113 Abstract | Full Text | | | | Anti-microRNA-378a Enhances Wound Healing Process by Upregulating Integrin Beta-3 and VimentinMTOPENHaoran Li, Leslie Chang, William W Du, Shaan Gupta, Azam Khorshidi, Michael Sefton and Burton B Yang Mol Ther 2014 22: 1839-1850; advance online publication, June 23, 2014; 10.1038/mt.2014.115 Abstract | Full Text | | | | Cytokine Conditioning Enhances Systemic Delivery and Therapy of an Oncolytic VirusElizabeth Ilett, Timothy Kottke, Oliver Donnelly, Jill Thompson, Candice Willmon, Rosa Diaz, Shane Zaidi, Matt Coffey, Peter Selby, Kevin Harrington, Hardev Pandha, Alan Melcher and Richard Vile Mol Ther 2014 22: 1851-1863; advance online publication, June 24, 2014; 10.1038/mt.2014.118 Abstract | Full Text | | | | Epicardial Placement of Mesenchymal Stromal Cell-sheets for the Treatment of Ischemic Cardiomyopathy; In Vivo Proof-of-concept StudyNobuko Tano, Takuya Narita, Masahiro Kaneko, Chiho Ikebe, Steven R Coppen, Niall G Campbell, Manabu Shiraishi, Yasunori Shintani and Ken Suzuki Mol Ther 2014 22: 1864-1871; advance online publication, June 16, 2014; 10.1038/mt.2014.110 Abstract | Full Text | | | | | Advertisement | | Submit to Molecular Therapy — Methods & Clinical Development (MTM), a new addition to the Molecular Therapy family of journals. As an online, open access journal, MTM articles are accessible to everyone. Find out more about submitting to MTM. | | | | | | Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Molecular Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. | | | |
No comments:
Post a Comment
Keep a civil tongue.